US Physical Therapy Inc (USPH) Stock Price

USPHStock

$77.32−11.49%52W

Market Cap$1.15B

P/E30.86x

PEG Ratio2.84

Div yield1.95%

Beta1.13

USPH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.73%

Price vs S&P 500 (4W)-5.10%

PEG Ratio2.84

VGM Score45.71

P/E Ratio (Annual)30.86x

Indicated Dividend Yield (Annual)1.95%

P/CF (Annual)16.27x

Book Value / Share (Quarterly)$30.79

P/TBV (Annual)3.91x

Indicated Dividend (Annual)$1.84

Revenue Growth (3Y)12.19%

Cash Flow / Share (Quarterly)$4.38

Payout Ratio (TTM)92.18%

Price vs S&P 500 (YTD)-12.87%

Gross Margin (TTM)19.02%

Net Profit Margin (TTM)4.36%

EPS (TTM)$2.29

10-Day Avg Trading Volume0.18M

EPS Excl Extra (TTM)$2.29

Revenue Growth (5Y)13.05%

EPS (Annual)$2.61

Dividend / Share (Annual)$1.81

ROI (Annual)6.20%

Gross Margin (Annual)19.20%

Net Profit Margin (5Y Avg)5.70%

Cash / Share (Quarterly)$1.87

P/E Basic Excl Extra (TTM)35.18x

Revenue Growth QoQ (YoY)7.89%

EPS Growth (5Y)-1.05%

P/E Normalized (Annual)30.86x

ROA (Last FY)3.29%

Revenue Growth TTM (YoY)13.73%

EBITD / Share (TTM)$6.72

ROE (5Y Avg)8.93%

Operating Margin (TTM)10.00%

Cash Flow / Share (Annual)$4.03

P/B Ratio2.60x

P/B Ratio (Quarterly)2.42x

Net Income / Employee (Annual)$9,400

EV / Revenue (TTM)1.76x

Net Interest Coverage (TTM)11.49x

ROA (TTM)2.88%

EPS Growth QoQ (YoY)-49.22%

EV / EBITDA (TTM)13.70x

EPS Incl Extra (Annual)$2.61

Current Ratio (Annual)1.01x

Quick Ratio (Quarterly)1.19x

3-Month Avg Trading Volume0.23M

52-Week Price Return-11.49%

EV / Free Cash Flow (Annual)22.92x

P/E Incl Extra (TTM)35.18x

Revenue / Employee (TTM)$189,400

Tangible BV / Share (Quarterly)$18.99

P/S Ratio (Annual)1.56x

Asset Turnover (Annual)0.65x

52-Week High$93.50

Operating Margin (5Y Avg)10.82%

EPS Excl Extra (Annual)$2.61

CapEx CAGR (5Y)12.99%

Tangible BV CAGR (5Y)6.66%

26-Week Price Return-10.48%

Quick Ratio (Annual)1.01x

13-Week Price Return23.12%

Total Debt / Equity (Annual)0.34x

Current Ratio (Quarterly)1.19x

Enterprise Value$1.40B

Revenue / Share Growth (5Y)9.26%

Asset Turnover (TTM)0.66x

Book Value / Share Growth (5Y)8.03%

Revenue / Employee (Annual)$186,000

Pretax Margin (Annual)9.96%

Cash / Share (Annual)$2.35

3-Month Return Std Dev34.28%

Gross Margin (5Y Avg)20.47%

Net Income / Employee (TTM)$8,300

EBITDA CAGR (5Y)7.35%

EBITDA Interim CAGR (5Y)0.89%

ROE (Last FY)8.31%

Net Interest Coverage (Annual)9.98x

EPS Basic Excl Extra (Annual)$2.61

P/FCF (TTM)17.90x

Receivables Turnover (TTM)8.48x

EV / Free Cash Flow (TTM)20.96x

Total Debt / Equity (Quarterly)0.44x

EPS Incl Extra (TTM)$2.29

Receivables Turnover (Annual)8.98x

ROI (TTM)5.27%

Dividend Growth Rate (5Y)41.45%

P/S Ratio (TTM)1.54x

Pretax Margin (5Y Avg)10.39%

Revenue / Share (Annual)$51.47

Tangible BV / Share (Annual)$20.07

Forward P/E25.06x

Free OCF CAGR (5Y)-7.97%

Price vs S&P 500 (52W)-29.81%

P/E Ratio (TTM)35.18x

EPS Growth TTM (YoY)3.68%

Year-to-Date Return-0.91%

5-Day Price Return-1.06%

EPS Normalized (Annual)$2.61

ROA (5Y Avg)3.60%

Net Profit Margin (Annual)5.07%

Month-to-Date Return-2.13%

Cash Flow / Share (TTM)$4.18

EBITD / Share (Annual)$7.18

EPS Growth (3Y)1.74%

Operating Margin (Annual)11.08%

LT Debt / Equity (Annual)0.32x

P/CF (TTM)14.62x

ROI (5Y Avg)6.39%

P/E Excl Extra (TTM)35.18x

LT Debt / Equity (Quarterly)0.41x

EPS Basic Excl Extra (TTM)$2.29

P/TBV (Quarterly)3.92x

Payout Ratio (Annual)69.13%

P/B Ratio (Annual)2.49x

Dividend / Share (TTM)$1.81

Pretax Margin (TTM)8.93%

Book Value / Share (Annual)$31.50

Price vs S&P 500 (13W)20.32%

Net Margin Growth (5Y)-9.43%

Dividend Yield (TTM)2.24%

Beta1.13x

P/FCF (Annual)20.03x

Revenue / Share (TTM)$52.45

ROE (TTM)7.12%

52-Week Low$58.19

vGradeC

gGradeD

mGradeC

vgmGradeC

USPH Earnings Surprise History

Q2 250.81est. 0.69

Q3 250.66est. 0.66

Q4 250.67est. 0.67

Q1 260.46est. 0.52

Q2 260.75est. 0.84

USPH Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.23

Industry Peers — Health Services(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
USPHUS Physical Therapy Inc	C	D	C	$77.32
LFSTLifeStance Health Group, Inc. Common Stock	D	B	B	$12.28
PRVAPrivia Health Group, Inc. Common Stock	C	B	D	$21.20
WGSGeneDx Holdings Corp. Class A Common Stock	F	B	B	$87.41
PIIIP3 Health Partners Inc. Common Stock	A	C	C	$10.31
INNVInnovAge Holding Corp. Common Stock	D	C	A	$10.92
OMDAOmada Health, Inc. Common Stock	F	A	B	$23.94
PNTGThe Pennant Group, Inc. Common Stock	D	B	C	$38.25
TALKTalkspace, Inc. Common Stock	F	B	C	$5.25
SRTAStrata Critical Medical, Inc. Class A Common Stock	C	B	B	$6.19
ALPSALPS Group Inc Ordinary Share	—	—	F	$0.31
EUDAEUDA Health Holdings Limited Ordinary Shares	C	B	F	$14.40
DCGODocGo Inc. Common Stock	A	D	F	$0.38
ATPCAgape ATP Corporation Common Stock	B	D	F	$2.37
VSEEVSee Health, Inc. Common Stock	A	D	F	$0.02
EUDAWEUDA Health Holdings Limited Warrant	—	—	D	$0.03
EVSDEaton Vance Short Duration Income ETF	—	—	D	$50.95
PIIIWP3 Health Partners Inc. Warrant	—	—	D	$0.01
SRTAWStrata Critical Medical, Inc. Warrants	—	—	F	$0.00
TALKWTalkspace, Inc. Warrant	—	—	F	$0.00
VSEEWVSee Health, Inc. Warrant	—	—	F	$0.02
WGSWWGeneDx Holdings Corp. Warrant	—	—	F	$0.00

About US Physical Therapy Inc

US Physical Therapy operates outpatient clinics specializing in orthopedic, sports medicine, post-operative, and neurological rehabilitation services. Revenue is derived from managed care, commercial insurance, Medicare, Medicaid, workers' compensation, and personal injury claims, with the physical therapy operations segment generating the majority of revenue.